Home > > > Report Detail

Global and United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Insights, Forecast to 2027

Publisher Name :
Date: 07-Sep-2021
No. of pages: 152
Inquire Before Buying

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.

Affecting 70-80% of patients undergoing chemotherapy, chemotherapy-induced nausea and vomiting (CINV) is one of chemotherapy's most debilitating side effects, often attributed as a leading cause of premature discontinuation of cancer treatment.

Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs key players include Haisco, Merck, Mundipharma, Qilu Pharma, Heron Therapeutics, Teva, etc. Global top six manufacturers hold a share about 30%.

North America is the largest market, with a share about 35%, followed by Europe and Asia-Pacific, both have a share about 60 percent.

In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 70%. And in terms of application, the largest application is Acute CINV, followed by Delayed CINV and Breakthrough CINV.

Market Analysis and Insights: Global and United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market

This report focuses on global and United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market.

In 2020, the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size was US$ 2328 million and it is expected to reach US$ 2139.8 million by the end of 2027, with a CAGR of -1.6% during 2021-2027. In United States the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Scope and Market Size

Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For United States market, this report focuses on the Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type

- 5-HT3 Inhibitors

- NK1 Inhibitors

- Others

Segment by Application

- Acute CINV

- Delayed CINV

- Breakthrough CINV

- Others

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Heron Therapeutics

- Merck

- Eisai

- Mundipharma

- Qilu Pharma

- Teva

- Novartis

- Roche

- Mylan

- Baxter

- GSK

- Helsinn

- Southwest Pharma

- Haisco

- Sun Pharma

Global and United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate by Type
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate by Application
1.3.2 Acute CINV
1.3.3 Delayed CINV
1.3.4 Breakthrough CINV
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size, Estimates and Forecasts
2.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue 2016-2027
2.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales 2016-2027
2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Region (2022-2027)
3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Competitor Landscape by Players
3.1 Global Top Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers by Sales
3.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers by Revenue
3.2.1 Key Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue in 2020
3.2.6 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Manufacturers
3.4 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturing Base Distribution, Product Types
3.4.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Type (2016-2021)
4.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021)
4.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2016-2021)
4.1.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Application (2016-2021)
5.1.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021)
5.1.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2016-2021)
5.1.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2016-2021)
5.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size YoY Growth 2016-2027
6.1.1 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales YoY Growth 2016-2027
6.1.2 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue YoY Growth 2016-2027
6.1.3 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Share in Global Market 2016-2027
6.2 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Players (International and Local Players)
6.2.1 United States Top Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players by Sales (2016-2021)
6.2.2 United States Top Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Players by Revenue (2016-2021)
6.3 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Historic Market Review by Type (2016-2021)
6.3.1 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Type (2016-2021)
6.3.2 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Type (2016-2021)
6.3.3 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Type (2016-2021)
6.4 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Type (2022-2027)
6.4.2 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Type (2022-2027)
6.4.3 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Forecast by Type (2022-2027)
6.5 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Historic Market Review by Application (2016-2021)
6.5.1 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Application (2016-2021)
6.5.2 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Application (2016-2021)
6.5.3 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price by Application (2016-2021)
6.6 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Application (2022-2027)
6.6.2 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Application (2022-2027)
6.6.3 United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size YoY Growth 2016-2027
7.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
7.2.1 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021)
7.2.2 North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size YoY Growth 2016-2027
9.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
9.2.1 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021)
9.2.2 Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
10.2.1 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021)
10.2.2 Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Heron Therapeutics
12.1.1 Heron Therapeutics Corporation Information
12.1.2 Heron Therapeutics Description and Business Overview
12.1.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
12.1.5 Heron Therapeutics Recent Development
12.2 Merck
12.2.1 Merck Corporation Information
12.2.2 Merck Description and Business Overview
12.2.3 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
12.2.5 Merck Recent Development
12.3 Eisai
12.3.1 Eisai Corporation Information
12.3.2 Eisai Description and Business Overview
12.3.3 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
12.3.5 Eisai Recent Development
12.4 Mundipharma
12.4.1 Mundipharma Corporation Information
12.4.2 Mundipharma Description and Business Overview
12.4.3 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
12.4.5 Mundipharma Recent Development
12.5 Qilu Pharma
12.5.1 Qilu Pharma Corporation Information
12.5.2 Qilu Pharma Description and Business Overview
12.5.3 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
12.5.5 Qilu Pharma Recent Development
12.6 Teva
12.6.1 Teva Corporation Information
12.6.2 Teva Description and Business Overview
12.6.3 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
12.6.5 Teva Recent Development
12.7 Novartis
12.7.1 Novartis Corporation Information
12.7.2 Novartis Description and Business Overview
12.7.3 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
12.7.5 Novartis Recent Development
12.8 Roche
12.8.1 Roche Corporation Information
12.8.2 Roche Description and Business Overview
12.8.3 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
12.8.5 Roche Recent Development
12.9 Mylan
12.9.1 Mylan Corporation Information
12.9.2 Mylan Description and Business Overview
12.9.3 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
12.9.5 Mylan Recent Development
12.10 Baxter
12.10.1 Baxter Corporation Information
12.10.2 Baxter Description and Business Overview
12.10.3 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
12.10.5 Baxter Recent Development
12.11 Heron Therapeutics
12.11.1 Heron Therapeutics Corporation Information
12.11.2 Heron Therapeutics Description and Business Overview
12.11.3 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Products Offered
12.11.5 Heron Therapeutics Recent Development
12.12 Helsinn
12.12.1 Helsinn Corporation Information
12.12.2 Helsinn Description and Business Overview
12.12.3 Helsinn Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Helsinn Products Offered
12.12.5 Helsinn Recent Development
12.13 Southwest Pharma
12.13.1 Southwest Pharma Corporation Information
12.13.2 Southwest Pharma Description and Business Overview
12.13.3 Southwest Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Southwest Pharma Products Offered
12.13.5 Southwest Pharma Recent Development
12.14 Haisco
12.14.1 Haisco Corporation Information
12.14.2 Haisco Description and Business Overview
12.14.3 Haisco Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Haisco Products Offered
12.14.5 Haisco Recent Development
12.15 Sun Pharma
12.15.1 Sun Pharma Corporation Information
12.15.2 Sun Pharma Description and Business Overview
12.15.3 Sun Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Sun Pharma Products Offered
12.15.5 Sun Pharma Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Industry Trends
13.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Drivers
13.3 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Challenges
13.4 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 5-HT3 Inhibitors
Table 3. Major Manufacturers of NK1 Inhibitors
Table 4. Major Manufacturers of Others
Table 5. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size Growth Rate by Application (2021-2027) & (M Units)
Table 6. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Regions (2016-2021) & (M Units)
Table 8. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Regions (2016-2021)
Table 9. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Region (2022-2027) & (M Units)
Table 11. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Manufacturers (2016-2021) (M Units)
Table 15. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 17. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Manufacturers (2016-2021)
Table 19. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs as of 2020)
Table 21. Key Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (2016-2021) (US$/Unit)
Table 22. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product Type
Table 24. Date of International Manufacturers Enter into Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Type (2016-2021) (M Units)
Table 27. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Type (2016-2021)
Table 28. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Type (2016-2021)
Table 30. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 31. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Type (2022-2027) & (M Units)
Table 32. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Application (2016-2021) (M Units)
Table 37. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Application (2016-2021)
Table 38. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Application (2016-2021)
Table 40. Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 41. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Forecast by Application (2022-2027) & (M Units)
Table 42. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 46. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) of Key Companies (2016-2021)
Table 47. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Company (2016-2021)
Table 48. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) by Company (2016-2021)
Table 49. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Company (2016-2021)
Table 50. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) by Type (2016-2021)
Table 51. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Type (2016-2021)
Table 52. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Type (2016-2021)
Table 54. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) by Type (2022-2027)
Table 55. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Type (2022-2027)
Table 56. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Type (2022-2027)
Table 58. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Type (2022-2027)
Table 59. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) by Application (2016-2021)
Table 60. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Application (2016-2021)
Table 61. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Application (2016-2021)
Table 63. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units) by Application (2022-2027)
Table 64. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Share by Application (2022-2027)
Table 65. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Share by Application (2022-2027)
Table 67. United States Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Price (US$/Unit) by Application (2022-2027)
Table 68. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021) & (M Units)
Table 69. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 70. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Region (2016-2021) & (M Units)
Table 73. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Region (2016-2021)
Table 76. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021) & (M Units)
Table 77. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 78. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 80. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021) & (M Units)
Table 81. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales by Country (2016-2021) & (M Units)
Table 85. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Revenue Market Share by Country (2016-2021)
Table 88. Heron Therapeutics Corporation Information
Table 89. Heron Therapeutics Description and Business Overview
Table 90. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Heron Therapeutics Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Product
Table 92. Heron Therapeutics Recent Development
Table 93. Merck Corporation Information
Table 94. Merck Description and Business Overview
Table 95. Merck Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Merck Product
Table 97. Merck Recent Development
Table 98. Eisai Corporation Information
Table 99. Eisai Description and Business Overview
Table 100. Eisai Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Eisai Product
Table 102. Eisai Recent Development
Table 103. Mundipharma Corporation Information
Table 104. Mundipharma Description and Business Overview
Table 105. Mundipharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Mundipharma Product
Table 107. Mundipharma Recent Development
Table 108. Qilu Pharma Corporation Information
Table 109. Qilu Pharma Description and Business Overview
Table 110. Qilu Pharma Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Qilu Pharma Product
Table 112. Qilu Pharma Recent Development
Table 113. Teva Corporation Information
Table 114. Teva Description and Business Overview
Table 115. Teva Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Teva Product
Table 117. Teva Recent Development
Table 118. Novartis Corporation Information
Table 119. Novartis Description and Business Overview
Table 120. Novartis Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Novartis Product
Table 122. Novartis Recent Development
Table 123. Roche Corporation Information
Table 124. Roche Description and Business Overview
Table 125. Roche Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Roche Product
Table 127. Roche Recent Development
Table 128. Mylan Corporation Information
Table 129. Mylan Description and Business Overview
Table 130. Mylan Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Mylan Product
Table 132. Mylan Recent Development
Table 133. Baxter Corporation Information
Table 134. Baxter Description and Business Overview
Table 135. Baxter Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Baxter Product
Table 137. Baxter Recent Development
Table 138. GSK Corporation Information
Table 139. GSK Description and Business Overview
Table 140. GSK Chemotheraphy Induced Nausea and Vomitting (CINV) Dr
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs